PlexBio Co., Ltd. (TPEX:6572)
Taiwan · Delayed Price · Currency is TWD 10.05
-0.05 (-0.50%)
Aug 12, 2025, 1:57 PM CST
PlexBio Market Cap
PlexBio has a market cap or net worth of 1.04 billion as of August 12, 2025. Its market cap has decreased by -26.37% in one year.
Market Cap
1.04B
Enterprise Value
631.82M
Revenue
128.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.05
Market Cap Chart
Since February 26, 2016, PlexBio's market cap has decreased from 1.58B to 1.04B, a decrease of -34.04%. That is a compound annual growth rate of -4.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 1.04B | -18.62% |
| Dec 31, 2024 | 1.28B | -12.41% |
| Dec 29, 2023 | 1.46B | 17.01% |
| Dec 30, 2022 | 1.25B | -32.68% |
| Dec 30, 2021 | 1.86B | -23.47% |
| Dec 31, 2020 | 2.42B | 30.10% |
| Dec 25, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 56.28B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.31B |
| Center Laboratories | 26.39B |
| Pegavision | 24.34B |